Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Swedberg

Showing results (221-230 of 471) with videos related to

Pageof 48
Sort By:
European Heart Journal|June 3, 2008
New-onset atrial fibrillation is an independent predictor of in-hospital mortality in hospitalized heart failure patients: results of the EuroHeart Failure SurveyMaximo Rivero-Ayerza, Wilma Scholte Op Reimer, Mattie Lenzen, et al.
Journal of the American College of Cardiology|February 21, 2019
Effects of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFrEFMichael R Zile, Eileen O'Meara, Brian Claggett, et al.
European Journal of Heart Failure|March 25, 2015
Twenty-four-hour heart rate lowering with ivabradine in chronic heart failure: insights from the SHIFT Holter substudyMichael Böhm, Jeffrey S Borer, John Camm, et al.
European Journal of Heart Failure|August 19, 2007
Prognostic importance of plasma NT-pro BNP in chronic heart failure in patients treated with a beta-blocker: results from the Carvedilol Or Metoprolol European Trial (COMET) trialLars G Olsson, Karl Swedberg, John G F Cleland, et al.
European Heart Journal|November 5, 2014
Prognostic importance of temporal changes in resting heart rate in heart failure patients: an analysis of the CHARM programAli Vazir, Brian Claggett, Pardeep Jhund, et al.
European Journal of Heart Failure|March 10, 2012
Gender and survival in patients with heart failure: interactions with diabetes and aetiology. Results from the MAGGIC individual patient meta-analysisManuel Martínez-Sellés, Robert N Doughty, Katrina Poppe, et al.
European Journal of Heart Failure|March 9, 2016
Non-adherence to ivabradine and placebo and outcomes in chronic heart failure: an analysis from SHIFTMichael Böhm, Suzanne M Lloyd, Ian Ford, et al.
Journal of the American College of Cardiology|August 29, 2023
Underutilization of Mineralocorticoid Antagonists in Patients With Heart Failure With Reduced Ejection FractionShingo Matsumoto, Toru Kondo, Pardeep S Jhund, et al.
Journal of the American College of Cardiology|July 2, 2013
Safety and efficacy of eplerenone in patients at high risk for hyperkalemia and/or worsening renal function: analyses of the EMPHASIS-HF study subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure)Romain Eschalier, John J V McMurray, Karl Swedberg, et al.
Journal of Cardiac Failure|July 4, 2012
The impact of chronic obstructive pulmonary disease in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST TrialRobert J Mentz, Philip H Schmidt, Mary J Kwasny, et al.
Pageof 48

Showing results (221-230 of 471) with videos related to

Sort By:
Pageof 48
European Heart Journal|June 3, 2008
New-onset atrial fibrillation is an independent predictor of in-hospital mortality in hospitalized heart failure patients: results of the EuroHeart Failure SurveyMaximo Rivero-Ayerza, Wilma Scholte Op Reimer, Mattie Lenzen, et al.
Journal of the American College of Cardiology|February 21, 2019
Effects of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFrEFMichael R Zile, Eileen O'Meara, Brian Claggett, et al.
European Journal of Heart Failure|March 25, 2015
Twenty-four-hour heart rate lowering with ivabradine in chronic heart failure: insights from the SHIFT Holter substudyMichael Böhm, Jeffrey S Borer, John Camm, et al.
European Journal of Heart Failure|August 19, 2007
Prognostic importance of plasma NT-pro BNP in chronic heart failure in patients treated with a beta-blocker: results from the Carvedilol Or Metoprolol European Trial (COMET) trialLars G Olsson, Karl Swedberg, John G F Cleland, et al.
European Heart Journal|November 5, 2014
Prognostic importance of temporal changes in resting heart rate in heart failure patients: an analysis of the CHARM programAli Vazir, Brian Claggett, Pardeep Jhund, et al.
European Journal of Heart Failure|March 10, 2012
Gender and survival in patients with heart failure: interactions with diabetes and aetiology. Results from the MAGGIC individual patient meta-analysisManuel Martínez-Sellés, Robert N Doughty, Katrina Poppe, et al.
European Journal of Heart Failure|March 9, 2016
Non-adherence to ivabradine and placebo and outcomes in chronic heart failure: an analysis from SHIFTMichael Böhm, Suzanne M Lloyd, Ian Ford, et al.
Journal of the American College of Cardiology|August 29, 2023
Underutilization of Mineralocorticoid Antagonists in Patients With Heart Failure With Reduced Ejection FractionShingo Matsumoto, Toru Kondo, Pardeep S Jhund, et al.
Journal of the American College of Cardiology|July 2, 2013
Safety and efficacy of eplerenone in patients at high risk for hyperkalemia and/or worsening renal function: analyses of the EMPHASIS-HF study subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure)Romain Eschalier, John J V McMurray, Karl Swedberg, et al.
Journal of Cardiac Failure|July 4, 2012
The impact of chronic obstructive pulmonary disease in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST TrialRobert J Mentz, Philip H Schmidt, Mary J Kwasny, et al.
Pageof 48